A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy
Yıl: 2022 Cilt: 54 Sayı: 2 Sayfa Aralığı: 133 - 137 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2022.20367 İndeks Tarihi: 05-07-2022
A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy
Öz: Objective: Cystic echinococcosis (CE) is rarely encountered in the spleen, even in areas where the disease is
endemic. There is no consensus in the literature concerning the treatment of splenic cystic echinococcosis.
This study was intended to compare the treatment results and factors affecting the selection of the spleenpreserving
approach or splenectomy in treatment.
Materials and Methods: Four hundred and seventy patients operated for cystic echinococcosis at a university
clinic between January 2010 and December 2019 were retrospectively evaluated. Splenic cystic echinococcosis
was identified in 22 patients (4.7%). Demographic features as well as clinical and laboratory findings of
patients who underwent splenectomy or spleen-preserving operations were compared between the groups.
Results: Spleen-preserving cystotomy was performed on 18 patients (81.8%), and splenectomy on 4 (18.2%).
Eleven patients (50%) had isolated cystic echinococcosis in the spleen, while another 11 (50%) had hepatic
and splenic cystic echinococcosis. The median cyst size was 10.0 cm (min: 3, max: 20). Splenectomy patients
had significantly larger cyst sizes (median, min-max; 8.0 cm, 3-15 cm vs. 15.0 cm, 10-20) (Z = 2.071, P = .042).
Postoperatively, 1 patient from the splenectomy group (25.0%) developed deep vein thrombosis, and another
from the cystotomy group (5.5%) developed pulmonary embolism. No other serious complications, re-operation
requirements, or recurrence were observed after a median follow-up period of 27.0 months (min: 5, max: 92).
Conclusion: Since no collections or recurrence were observed, and splenic functions were preserved in
patients who underwent spleen-preserving cystotomy, we recommend the use of spleen-protective cystotomy.
Splenectomy should be employed in patients with cyst diameters exceeding 10 cm, with a central
location, and in cases with difficult cavity management and a high risk of developing postoperative collections.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Akhan O, Koroglu M. Hydatid disease of the spleen. Paper presented at: Seminars in Ultrasound, CT and MRI; 2007. [CrossRef]
- 2. Safioleas M, Misiakos E, Manti C. Surgical treatment for splenic hydatidosis. World J Surg. 1997;21(4):374-378. [CrossRef]
- 3. Yazıcı P, Aydın U, Ersin S, Kaplan H. Splenic Hydatid Cyst: Clinical Study. EAJM 2007;39: 25–27.
- 4. Dar MA, Shah OJ, Wani NA, Khan FA. Shah P. Surgical management of splenic hydatidosis. Surg Today. 2002;32(3):224-229.
- 5. Ozogul B, Kisaoglu A, Atamanalp SS, et al. Splenic hydatid cysts: 17 cases. Indian J Surg. 2015;77(Suppl 2):257-260. [CrossRef]
- 6. Eris C, Akbulut S, Yildiz MK, et al. Surgical approach to splenic hydatid cyst: single center experience. Int Surg. 2013;98(4):346-353. [CrossRef]
- 7. Ozdogan M, Baykal A, Keskek M, Yorgancy K, Hamaloglu E, Sayek I. Hydatid cyst of the spleen: treatment options. Int Surg. 2001;86(2): 122-126.
- 8. Arikanoglu Z, Taskesen F, Gumus H, et al. Selecting a surgical modality to treat a splenic hydatid cyst: total splenectomy or spleen-saving surgery? J Gastrointest Surg. 2012;16(6):1189-1193. [CrossRef]
- 9. Durgun V, Kapan S, Kapan M, Karabiçak I, Aydogan F. Goksoy EJD. Primary splenic hydatidosis. Dig Surg. 2003;20(1):38-41.
- 10. Puryan K, Karadayi K, Topcu O, et al. Chlorhexidine gluconate: an ideal scolicidal agent in the treatment of intraperitoneal hydatidosis? World J Surg. 2005;29(2):227-230. [CrossRef]
- 11. Temiz A, Albayrak y, Er s, Albayrak A, OBJAOC OB, MEDICINE E. Primary splenic hydatidosis: case series. Archives of Clinical and Experimental Medicine. 2017;2(2):31-34. [CrossRef]
- 12. Gomez I Gavara C, López-Andújar R, Belda Ibáñez T, et al. Review of the treatment of liver hydatid cysts. World J Gastroenterol. 2015;21(1):124-131. [CrossRef]
- 13. Zaharie F, Bartos D, Mocan L, Zaharie R, Iancu C, Tomus C. Open or laparoscopic treatment for hydatid disease of the liver? A 10-year singleinstitution experience. Surg Endosc. 2013;27(6): 2110-2116. [CrossRef]
- 14. Akhan O, Akkaya S, Dağoğlu MG, et al. Percutaneous treatment of splenic cystic echinococcosis: results of 12 cases. Cardiovasc Intervent Radiol. 2016;39(3):441-446. [CrossRef]
- 15. Golemanov B, Grigorov N, Mitova R, et al. Efficacy and safety of PAIR for cystic echinococcosis: experience on a large series of patients from Bulgaria. Am J Trop Med Hyg. 2011;84(1):48-51. [CrossRef]
- 16. Atmatzidis KS, Pavlidis TE, Papaziogas BT, Mirelis C, Papaziogas TB. Recurrence and long-term outcome after open cystectomy with omentoplasty for hepatic hydatid disease in an endemic area. Acta Chir Belg. 2005;105(2):198-202. [CrossRef]
- 17. Aydin U, Yazici P, Onen Z, et al. The optimal treatment of hydatid cyst of the liver: radical surgery with a significant reduced risk of recurrence. Turk J Gastroenterol. 2008;19(1):33-39.
- 18. Vagianos CE, Karavias DD, Kakkos SK, Vagenas CA, Androulakis JA. Conservative surgery in the treatment of hepatic hydatidosis. Eur J Surg. 1995;161(6):415-420.
- 19. Kyaw MH, Holmes EM, Toolis F, et al. Evaluation of severe infection and survival after splenectomy. Am J Med. 2006;119(3):276:e271-e276. e277. [CrossRef]
- 20. Cadili A, de Gara C. Complications of splenectomy. Am J Med. 2008;121(5):371-375. [CrossRef]
- 21. Thomsen RW, Schoonen WM, Farkas DK, et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med. 2009;151(8):546-555. [CrossRef]
- 22. Thomsen RW, Schoonen WM, Farkas DK, Riis A, Fryzek JP, Sørensen HT. Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study. J Thromb Haemost. 2010;8(6):1413-1416. [CrossRef]
APA | Korkut E, Aksungur N, Ozturk G (2022). A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. , 133 - 137. 10.5152/eurasianjmed.2022.20367 |
Chicago | Korkut Ercan,Aksungur Nurhak,Ozturk Gurkan A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. (2022): 133 - 137. 10.5152/eurasianjmed.2022.20367 |
MLA | Korkut Ercan,Aksungur Nurhak,Ozturk Gurkan A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. , 2022, ss.133 - 137. 10.5152/eurasianjmed.2022.20367 |
AMA | Korkut E,Aksungur N,Ozturk G A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. . 2022; 133 - 137. 10.5152/eurasianjmed.2022.20367 |
Vancouver | Korkut E,Aksungur N,Ozturk G A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. . 2022; 133 - 137. 10.5152/eurasianjmed.2022.20367 |
IEEE | Korkut E,Aksungur N,Ozturk G "A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy." , ss.133 - 137, 2022. 10.5152/eurasianjmed.2022.20367 |
ISNAD | Korkut, Ercan vd. "A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy". (2022), 133-137. https://doi.org/10.5152/eurasianjmed.2022.20367 |
APA | Korkut E, Aksungur N, Ozturk G (2022). A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. Eurasian Journal of Medicine, 54(2), 133 - 137. 10.5152/eurasianjmed.2022.20367 |
Chicago | Korkut Ercan,Aksungur Nurhak,Ozturk Gurkan A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. Eurasian Journal of Medicine 54, no.2 (2022): 133 - 137. 10.5152/eurasianjmed.2022.20367 |
MLA | Korkut Ercan,Aksungur Nurhak,Ozturk Gurkan A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. Eurasian Journal of Medicine, vol.54, no.2, 2022, ss.133 - 137. 10.5152/eurasianjmed.2022.20367 |
AMA | Korkut E,Aksungur N,Ozturk G A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. Eurasian Journal of Medicine. 2022; 54(2): 133 - 137. 10.5152/eurasianjmed.2022.20367 |
Vancouver | Korkut E,Aksungur N,Ozturk G A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy. Eurasian Journal of Medicine. 2022; 54(2): 133 - 137. 10.5152/eurasianjmed.2022.20367 |
IEEE | Korkut E,Aksungur N,Ozturk G "A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy." Eurasian Journal of Medicine, 54, ss.133 - 137, 2022. 10.5152/eurasianjmed.2022.20367 |
ISNAD | Korkut, Ercan vd. "A Retrospective Evaluation of Spleen Hydatid Cyst Treatments: The Spleen-Preserving Conservative Approach is Preferable to Splenectomy". Eurasian Journal of Medicine 54/2 (2022), 133-137. https://doi.org/10.5152/eurasianjmed.2022.20367 |